Vascular Therapies, Inc.

- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2001-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.vasculartx.com
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
- Conditions
- Complication of HemodialysisArteriovenous FistulaEnd Stage Kidney DiseaseESRDChronic Kidney FailureEnd Stage Renal DiseaseComplication of Renal DialysisVascular Access Complication
- Interventions
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Vascular Therapies, Inc.
- Target Recruit Count
- 136
- Registration Number
- NCT05425056
- Locations
- 🇺🇸
Veterans Affairs San Diego Health Center, San Diego, California, United States
🇺🇸Lundquist Institute for Biomedical Innovation, Torrance, California, United States
🇺🇸MedStar Cardiovascular Research Network at MedStar Washington Hospital Center, Washington, District of Columbia, United States
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
- Conditions
- End Stage Kidney DiseaseArteriovenous FistulaEnd Stage Renal DiseaseESRDChronic Kidney FailureVascular Access ComplicationComplication of Renal DialysisComplication of Hemodialysis
- Interventions
- First Posted Date
- 2015-07-31
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Vascular Therapies, Inc.
- Target Recruit Count
- 269
- Registration Number
- NCT02513303
- Locations
- 🇺🇸
Nephrology Consultants, LLC, Huntsville, Alabama, United States
🇺🇸AKDHC Medical Research Service, Phoenix, Arizona, United States
🇺🇸San Diego Institute of Medical Research, Escondido, California, United States